M Ducreux

Taking into account successive treatment lines in the analysis of a colorectal cancer randomised trial.

S Michiels, J. Pignon, M. Ducreux, 2013, European journal of cancer.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

J P Pignon, J. Pignon, M. Ducreux, 2001, The New England journal of medicine.

Resection of liver metastases from colorectal cancer: the real impact of the surgical margin.

J P Pignon, J. Pignon, M. Ducreux, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.

R. Labianca, J. Berlin, K. Haustermans, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion.

A Roche, T. de Baère, M. Ducreux, 2002, AJR. American journal of roentgenology.

Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases

J P Pignon, J. Pignon, M. Ducreux, 1998, Journal of surgical oncology.

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

R. Labianca, M. Ducreux, J. Taïeb, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

J Ricke, T Maughan, W. Oyen, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.